Intermittent fasting in the treatment of type 2 diabetes
The increasing prevalence of type 2 diabetes mellitus (T2DM) has inspired researchers to investigate therapies and tools supporting the treatment of this disease. One such tool is intermittent fasting (IF). Given the nature and mechanism of action of IF, it would be logical for it to have a benefici...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Nutrition |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2025.1629154/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849340539271380992 |
|---|---|
| author | Damian Dyńka Łukasz Rodzeń Mateusz Rodzeń Dorota Łojko Adam Deptuła Żaneta Grzywacz Sebastian Kraszewski Karolina Bartoń Peter Martin Anna Małgorzata Deptuła Ken Berry David Unwin |
| author_facet | Damian Dyńka Łukasz Rodzeń Mateusz Rodzeń Dorota Łojko Adam Deptuła Żaneta Grzywacz Sebastian Kraszewski Karolina Bartoń Peter Martin Anna Małgorzata Deptuła Ken Berry David Unwin |
| author_sort | Damian Dyńka |
| collection | DOAJ |
| description | The increasing prevalence of type 2 diabetes mellitus (T2DM) has inspired researchers to investigate therapies and tools supporting the treatment of this disease. One such tool is intermittent fasting (IF). Given the nature and mechanism of action of IF, it would be logical for it to have a beneficial effect on T2DM patients. This study analyzes the role of IF in the treatment of type 2 diabetes, used alongside standard recommendations, based on the current literature available to the authors. The authors discuss the benefits of IF in T2DM treatment, such as improved glycaemic control, improved insulin sensitivity, facilitated adherence to recommendations, weight reduction, and lower risk of complications. This study covers the results of meta-analyses, systematic reviews, and randomized controlled trials (RCTs) and shows how novel technologies, including continuous glucose monitors and mobile applications, can support the implementation of IF. The importance of safety monitoring is also highlighted, particularly in insulin-treated patients due to the potential risk of hypoglycaemia. |
| format | Article |
| id | doaj-art-63b1aa38444e413fbfe1d7142ee106c4 |
| institution | Kabale University |
| issn | 2296-861X |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Nutrition |
| spelling | doaj-art-63b1aa38444e413fbfe1d7142ee106c42025-08-20T03:43:54ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2025-08-011210.3389/fnut.2025.16291541629154Intermittent fasting in the treatment of type 2 diabetesDamian Dyńka0Łukasz Rodzeń1Mateusz Rodzeń2Dorota Łojko3Adam Deptuła4Żaneta Grzywacz5Sebastian Kraszewski6Karolina Bartoń7Peter Martin8Anna Małgorzata Deptuła9Ken Berry10David Unwin11Institute of Health Sciences, Faculty of Medical and Health Sciences, University of Siedlce, Siedlce, PolandRodzen Brothers Foundation, Wieleń, PolandRodzen Brothers Foundation, Wieleń, PolandDepartment of Psychiatry, Poznan University of Medical Science, Poznan, PolandFaculty of Production Engineering and Logistics, Opole University of Technology, Opole, PolandFaculty of Production Engineering and Logistics, Opole University of Technology, Opole, PolandDepartment of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Wroclaw, PolandKarolina Bartoń Food Coach, Warsaw, PolandFunmed Clinics, Vastra Hamngatan, Gothenburg, SwedenFaculty of Production Engineering and Logistics, Opole University of Technology, Opole, PolandIndependent Researcher, Holladay, TN, United StatesFaculty of Health Social Care and Medicine, Edge Hill University, Ormskirk, United KingdomThe increasing prevalence of type 2 diabetes mellitus (T2DM) has inspired researchers to investigate therapies and tools supporting the treatment of this disease. One such tool is intermittent fasting (IF). Given the nature and mechanism of action of IF, it would be logical for it to have a beneficial effect on T2DM patients. This study analyzes the role of IF in the treatment of type 2 diabetes, used alongside standard recommendations, based on the current literature available to the authors. The authors discuss the benefits of IF in T2DM treatment, such as improved glycaemic control, improved insulin sensitivity, facilitated adherence to recommendations, weight reduction, and lower risk of complications. This study covers the results of meta-analyses, systematic reviews, and randomized controlled trials (RCTs) and shows how novel technologies, including continuous glucose monitors and mobile applications, can support the implementation of IF. The importance of safety monitoring is also highlighted, particularly in insulin-treated patients due to the potential risk of hypoglycaemia.https://www.frontiersin.org/articles/10.3389/fnut.2025.1629154/fulltype 2 diabetes mellitus (T2DM)intermittent fasting (IF)insulin resistanceglucoseinsulinbody weight |
| spellingShingle | Damian Dyńka Łukasz Rodzeń Mateusz Rodzeń Dorota Łojko Adam Deptuła Żaneta Grzywacz Sebastian Kraszewski Karolina Bartoń Peter Martin Anna Małgorzata Deptuła Ken Berry David Unwin Intermittent fasting in the treatment of type 2 diabetes Frontiers in Nutrition type 2 diabetes mellitus (T2DM) intermittent fasting (IF) insulin resistance glucose insulin body weight |
| title | Intermittent fasting in the treatment of type 2 diabetes |
| title_full | Intermittent fasting in the treatment of type 2 diabetes |
| title_fullStr | Intermittent fasting in the treatment of type 2 diabetes |
| title_full_unstemmed | Intermittent fasting in the treatment of type 2 diabetes |
| title_short | Intermittent fasting in the treatment of type 2 diabetes |
| title_sort | intermittent fasting in the treatment of type 2 diabetes |
| topic | type 2 diabetes mellitus (T2DM) intermittent fasting (IF) insulin resistance glucose insulin body weight |
| url | https://www.frontiersin.org/articles/10.3389/fnut.2025.1629154/full |
| work_keys_str_mv | AT damiandynka intermittentfastinginthetreatmentoftype2diabetes AT łukaszrodzen intermittentfastinginthetreatmentoftype2diabetes AT mateuszrodzen intermittentfastinginthetreatmentoftype2diabetes AT dorotałojko intermittentfastinginthetreatmentoftype2diabetes AT adamdeptuła intermittentfastinginthetreatmentoftype2diabetes AT zanetagrzywacz intermittentfastinginthetreatmentoftype2diabetes AT sebastiankraszewski intermittentfastinginthetreatmentoftype2diabetes AT karolinabarton intermittentfastinginthetreatmentoftype2diabetes AT petermartin intermittentfastinginthetreatmentoftype2diabetes AT annamałgorzatadeptuła intermittentfastinginthetreatmentoftype2diabetes AT kenberry intermittentfastinginthetreatmentoftype2diabetes AT davidunwin intermittentfastinginthetreatmentoftype2diabetes |